Immunology Pipeline Includes New Approvals, Expanded Indications for Dermatology, Reparatory, and GI
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
Immunology drugs represent a significant portion of the current new drug pipeline and are forecasted as a key area of growth for specialty pharmacy. At the 2022 American Society of Health-System Pharmacists Summer Meetings & Exhibition,1 held in Phoenix, Arizona, Caitlyn Anne Young, PharmD, a PGY-2 Investigational Drugs and Research Pharmacy Resident at Michigan Medicine in Ann Arbor, shared the latest updates in immunology therapies with a. specific focus on dermatology, gastrointestinal, and respiratory conditions.
Check out our coverage of the 2022 ASHP Summer Meetings and Exhibition to learn more about the latest in the specialty drug pipeline.
Slideshow: Immunology Pipeline: Dermatology, Gastrointestinal, and Respiratory
Reference
- Young CA, Pleva M, Banks AM. Specialty pipeline updates II: autoimmune and emerging therapies. Presented at: American Society of Health-System Pharmacists Summer Meeting & Exhibition; June 11-15, 2022; Phoenix, AZ.
